Growth hormone treatment in adults with Prader-Willi syndrome: The Scandinavian study

Endocrine

Volumn 41, Issue 2, 2012, Pages 191-199

  Sode Carlsen, Rasmus ^a   Farholt, Stense ^a   Rabben, Kai Fr ^b   Bollerslev, Jens ^c   Schreiner, Thomas ^c   Jurik, Anne Grethe ^a   Christiansen, Jens Sandahl ^a   Höybye, Charlotte ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University of Oslo ^*

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body composition; GH; PWS

Indexed keywords

GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; BODY COMPOSITION; BODY MASS; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; FEMALE; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LEG EDEMA; LIPID METABOLISM; MALE; MULTICENTER STUDY; NAUSEA; OPEN STUDY; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PHYSICAL PERFORMANCE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCANDINAVIA; THIGH;

EID: 84862684301     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9560-4     Document Type: Review

References (55)

1. A. Prader, A. Labhart, H. Willi, Ein syndrom von adipositas, kleinwuchs, kryptorchidismus und oligophrenie nach myotonieartigem zustand in neugeborenalter. Schweiz. Med. Wochenschr. 86, 1260 (1956)
2. P. Burman, E.M. Ritzen, A.C. Lindgren, Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr. Rev. 22, 787-799 (2001) (Pubitemid 34214295)
3. G. Gillessen-Kaesbach, S. Gross, S. Kaya-Westerloh, E. Passarge, B. Horsthemke, DNA methylation based testing of 450 patients suspected of having Prader-Willi syndrome. J. Med. Genet. 32, 88-92 (1995)
4. M. Gunay-Aygun, S. Schwartz, S. Heeger, M.A. O'Riordan, S.B. Cassidy, The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 108, E92 (2001)
5. V.A. Holm, S.B. Cassidy, M.G. Butler, J.M. Hanchett, L.R. Greenswag, B.Y. Whitman, F. Greenberg, Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91, 398-402 (1993) (Pubitemid 23042323)
6. B.P. Hauffa, G. Schlippe, M. Roos, G. Gillessen-Kaesbach, T. Gasser, Spontaneous growth in German children and adolescents with genetically confirmed Prader-Willi syndrome. Acta Paediatr. 89, 1302-1311 (2000)
7. T. Eldar-Geva, H.J. Hirsch, F. Benarroch, O. Rubinstein, V. Gross-Tsur, Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur. J. Endocrinol. 162, 377-384 (2010)
8. H.J. Hirsch, T. Eldar-Geva, F. Benarroch, O. Rubinstein, V. Gross-Tsur, Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 94, 2262-2268 (2009)
9. A. Akefeldt, C.J. Tornhage, C. Gillberg, A woman with Prader- Willi syndrome gives birth to a healthy baby girl'. Dev. Med. Child Neurol. 41, 789-790 (1999) (Pubitemid 29511934)
10. A. Schulze, H. Mogensen, B. Hamborg-Petersen, N. Graem, J.R. Ostergaard, K. Brondum-Nielsen, Fertility in Prader-Willi syndrome: a case report with Angelman syndrome in the offspring. Acta Paediatr. 90, 455-459 (2001) (Pubitemid 32328471)
11. J.E. Whittington, A.J. Holland, T. Webb, J. Butler, D. Clarke, H. Boer, Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J. Med. Genet. 38, 792-798 (2001) (Pubitemid 33032939)
12. K. Buiting, Prader-Willi syndrome and Angelman syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 154C, 365-376 (2010)
13. A.L. Carrel, S.E. Myers, B.Y. Whitman, D.B. Allen, Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J. Clin. Endocrinol. Metab. 87, 1581-1585 (2002) (Pubitemid 34615243)
14. A.L. Carrel, S.E. Myers, B.Y. Whitman, D.B. Allen, Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study. J. Pediatr. 134, 215-221 (1999) (Pubitemid 29089047)
15. D.A. Festen, R. de Lind van Wijngaarden, M. van Eekelen, B.J. Otten, J.M. Wit, H.J. Duivenvoorden, A.C. Hokken-Koelega, Randomized controlled growth hormone trial: Effects on anthropometry, body composition, and body proportions in a large group of children with Prader-Willi syndrome. Clin. Endocrinol. (Oxf.) 69, 443-451 (2008)
16. S.E. Myers, A.L. Carrel, B.Y. Whitman, D.B. Allen, Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader- Willi syndrome. J. Pediatr. 137, 42-49 (2000) (Pubitemid 30470921)
17. D.A. Festen, M. Wevers, A.C. Lindgren, B. Bohm, B.J. Otten, J.M. Wit, H.J. Duivenvoorden, A.C. Hokken-Koelega, Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin. Endocrinol. (Oxf.) 68, 919-925 (2008) (Pubitemid 351703942)
18. C. Höybye, Endocrine and metabolic aspects of adult Prader- Willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm. IGF Res. 14(1), 1-15 (2004) (Pubitemid 38094239)
19. P.V. Carroll, E.R. Christ, B.A. Bengtsson, L. Carlsson, J.S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, P.H. Sonksen, T. Tanaka, M. Thorner, Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 83, 382-395 (1998) (Pubitemid 28496511)
20. M.D. Jensen, J.A. Kanaley, J.E. Reed, P.F. Sheedy, Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am. J. Clin. Nutr. 61, 274-278 (1995)
21. H. Norrelund, K.Y. Hove, E. Brems-Dalgaard, A.G. Jurik, L.P. Nielsen, S. Nielsen, J.O. Jorgensen, J. Weeke, N. Moller, Muscle mass and function in thyrotoxic patients before and during medical treatment. Clin. Endocrinol. (Oxf.) 51, 693-699 (1999) (Pubitemid 30050818)
22. G. Aimaretti, G. Corneli, P. Razzore, S. Bellone, C. Baffoni, E. Arvat, F. Camanni, E. Ghigo, Comparison between insulininduced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J. Clin. Endocrinol. Metab. 83, 1615-1618 (1998) (Pubitemid 28501031)
23. G. Corneli, S.C. Di, R. Baldelli, S. Rovere, V. Gasco, C.G. Croce, S. Grottoli, M. Maccario, A. Colao, G. Lombardi, E. Ghigo, F. Camanni, G. Aimaretti, The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur. J. Endocrinol. 153, 257-264 (2005) (Pubitemid 41174451)
24. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1), S43-S48 (2006)
25. J. Frystyk, b. Dinesen, H. Orskov, Non-competitive time-resolved immunofluorometric assays for determination of human insulinlike growth factor I and II. Growth Regul. 5, 169-176 (1995) (Pubitemid 26018330)
26. M. Albareda, J. Rodriguez-Espinosa, M. Murugo, A. de Leiva A, R. Corcoy, Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43, 1507-1511 (2000) (Pubitemid 32734856)
27. E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, G. Targher, M. Alberiche, R.C. Bonadonna, M. Muggeo, Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47, 1643-1649 (1998) (Pubitemid 28445355)
28. J.M. Guralnik, E.M. Simonsick, L. Ferrucci, R.J. Glynn, L.F. Berkman, D.G. Blazer, P.A. Scherr, R.B. Wallace, A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J. Gerontol. 49, M85-M94 (1994) (Pubitemid 24100267)
29. R. Sode-Carlsen, S. Farholt, K.F. Rabben, J. Bollerslev, T. Schreiner, A.G. Jurik, J.S. Christiansen, C. Höybye, Body Composition, endocrine and metabolic profiles in adults with Prader-Willi Syndrome. Growth Horm. IGF-I Res. 20, 179-184 (2010)
30. R. Sode-Carlsen, S. Farholt, K.F. Rabben, J. Bollerslev, T. Schreiner, A.G. Jurik, J.S. Christiansen, C. Höybye, One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition-results from a randomised, placebo controlled study. J. Clin. Endocrinol. Metab. 95, 4943-4950 (2010)
31. R. Sode-Carlsen, S. Farholt, K.F. Rabben, J. Bollerslev, T. Schreiner, A.G. Jurik, J. Frystyk, J.S. Christiansen, C. Höybye, Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. Growth Horm. IGF-I Res. 21, 185-190 (2011)
32. C. Hoybye, J. Frystyk, M. Thoren, The growth hormone-insulinlike growth factor axis in adult patients with Prader Willi syndrome. Growth Horm. IGF Res. 13, 269-274 (2003) (Pubitemid 37161681)
33. J.V. Butler, J.E. Whittington, A.J. Holland, H. Boer, D. Clarke, T. Webb, Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev. Med. Child Neurol. 44, 248-255 (2002) (Pubitemid 34406514)
34. Z. Talebizadeh, M.G. Butler, Insulin resistance and obesityrelated factors in Prader-Willi syndrome: comparison with obese subjects. Clin. Genet. 67, 230-239 (2005) (Pubitemid 40277903)
35. W.B. Zipf, Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy. Acta Paediatr. Suppl. 88, 115-117 (1999) (Pubitemid 30007347)
36. A.P. Goldstone, E.L. Thomas, A.E. Brynes, J.D. Bell, G. Frost, N. Saeed, J.V. Hajnal, J.K. Howard, A. Holland, S.R. Bloom, Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J. Clin. Endocrinol. Metab. 86, 4330-4338 (2001) (Pubitemid 32848555)
37. M.F. Theodoro, Z. Talebizadeh, M.G. Butler, Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Obesity (Silver Spring) 14, 1685-1690 (2006) (Pubitemid 46214789)
38. E.G. van Mil, K.R. Westerterp, W.J. Gerver, W.D. Van Marken Lichtenbelt, A.D. Kester, W.H. Saris, Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone function. J. Pediatr. 139, 708-714 (2001) (Pubitemid 33097438)
39. C. Hoybye, Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome. Acta Paediatr. 96, 410-413 (2007) (Pubitemid 46439476)
40. G. Grugni, P. Marzullo, L. Ragusa, A. Sartorio, G. Trifiro, A. Liuzzi, A. Crino, Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome. Clin. Endocrinol. (Oxf.) 65, 492-499 (2006) (Pubitemid 44414273)
41. L.A. Gondoni, L. Vismara, P. Marzullo, R. Vettor, A. Liuzzi, G. Grugni, Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome. J. Endocrinol. Invest. 31, 765-772 (2008)
42. P. Marzullo, C. Marcassa, R. Campini, E. Eleuteri, A. Minocci, A. Sartorio, R. Vettor, A. Liuzzi, G. Grugni, Conditional cardiovascular response to growth hormone therapy in adult patients with Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 92, 1364-1371 (2007) (Pubitemid 46556411)
43. M.G. Butler, M.F. Theodoro, D.C. Bittel, J.E. Donnelly, Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet A 143, 449-459 (2007) (Pubitemid 46348916)
44. G. Grugni, A. Crino, P. Bertocco, P. Marzullo, Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome. Am. J Med. Genet. A 95, 130-134 (2009)
45. C. Hoybye, A. Hilding, H. Jacobsson, M. Thoren, Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J. Clin. Endocrinol. Metab. 87, 3590-3597 (2002)
46. P. Marzullo, C. Marcassa, R. Campini, E. Eleuteri, A. Minocci, L. Priano, P. Temporelli, A. Sartorio, R. Vettor, A. Liuzzi, G. Grugni, The impact of growth hormone/insulin-like growth factor- I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 90, 5639-5646 (2005) (Pubitemid 41415470)
47. H.R. Mogul, P.D. Lee, B.Y. Whitman, W.B. Zipf, M. Frey, S. Myers, M. Cahan, B. Pinyerd, A.L. Southren, Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. J. Clin. Endocrinol. Metab. 93, 1238-1245 (2008) (Pubitemid 351519716)
48. C.J. Partsch, C. Lammer, G. Gillessen-Kaesbach, R. Pankau, Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion. Growth Horm. IGF Res. 10(Suppl B), S81-S85 (2000) (Pubitemid 30637221)
49. L. Vismara, M. Romei, M. Galli, A. Montesano, G. Baccalaro, M. Crivellini, G. Grugni, Clinical implications of gait analysis in the rehabilitation of adult patients with "Prader-Willi" Syndrome: a cross-sectional comparative study ("Prader-Willi" Syndrome vs matched obese patients and healthy subjects). J. Neuroeng. Rehabil. 4, 14 (2007)
50. U. Eiholzer, Y. Nordmann, D. l'Allemand, M. Schlumpf, S. Schmid, K. Kromeyer-Hauschild, Improving body composition and physical activity in Prader-Willi Syndrome. J. Pediatr. 142, 73-78 (2003) (Pubitemid 36106393)
51. M. Schlumpf, U. Eiholzer, M. Gygax, S. Schmid, I. van der Sluis, D. l'Allemand, A daily comprehensive muscle training programme increases lean mass and spontaneous activity in children with Prader-Willi syndrome after 6 months. J. Pediatr. Endocrinol. Metab. 19, 65-74 (2006) (Pubitemid 43257422)
52. J.M. Guralnik, L. Ferrucci, E.M. Simonsick, M.E. Salive, R.B. Wallace, Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N. Engl. J. Med. 332, 556-561 (1995)
53. R. Sode-Carlsen, S. Farholt, K.F. Rabben, J. Bollerslev, T. Schreiner, J.S. Christiansen, C. Höybye, Assessment of physical function in adults with Prader-Willi syndrome. Disabil. Rehabil. 31, 1780-1784 (2009)
54. H. Hakonarson, J. Moskovitz, K.L. Daigle, S.B. Cassidy, M.M. Cloutier, Pulmonary function abnormalities in Prader-Willi syndrome. J. Pediatr. 126, 565-570 (1995)
55. A.M. Haqq, D.D. Stadler, R.H. Jackson, R.G. Rosenfeld, J.Q. Purnell, S.H. LaFranchi, Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 88, 2206-2212 (2003) (Pubitemid 36549898)